Lieke Joosten

Radboud University Nijmegen — Netherlands

Medicine · Health Sciences

23h-index1.9kcitations69works11.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic function and diabetes(30), Neuroendocrine Tumor Research Advances(23), Diabetes and associated disorders(20), Lung Cancer Research Studies(13), Diabetes Management and Research(9)

Publications69 total

Radiopharmaceutical formulation and preliminary clinical dosimetry of [177Lu]Lu-DOTA-MGS5 for application in peptide receptor radionuclide therapy
European Journal of Nuclear Medicine and Molecular Imaging·2024· 5 citedOpen Access
Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas
EJNMMI Research·2024· 3 citedOpen Access
POS0134 SYSTEMIC INFLAMMATORY CYTOKINE PROFILES IN PATIENTS WITH GOUT DURING FLARE, INTERCRITICAL, AND TREAT-TO-TARGET PHASES: TNFSF14 AS NEW BIOMARKER
Annals of the Rheumatic Diseases·2024
Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands
Pharmaceuticals·2024· 38 citedOpen Access
New Radiolabeled Exendin Analogues Show Reduced Renal Retention
Molecular Pharmaceutics·2023· 5 citedOpen Access
Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
Pharmaceuticals·2023· 34 citedOpen Access
Repeated Application and Removal of Polyisocyanopeptide Hydrogel Wound Dressings in a Splinted Full-Thickness Wound Model
International Journal of Molecular Sciences·2023· 3 citedOpen Access
Effect of N-Terminal Peptide Modifications on In Vitro and In Vivo Properties of 177Lu-Labeled Peptide Analogs Targeting CCK2R
Pharmaceutics·2023· 7 citedOpen Access
Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)
European Journal of Nuclear Medicine and Molecular Imaging·2022· 6 citedOpen Access
Effect of Peptide Length on <em>in Vitro</em> and <em>in Vivo</em> Properties of <sup>177</sup>Lu-labeled Peptide Analogs Targeting CCK2R
Preprints.org·2022· 1 citedOpen Access
Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)
Research Square (Research Square)·2022Open Access
111In-exendin SPECT imaging suggests presence of residual beta cells in patients with longstanding type 1 diabetes
Nuklearmedizin - NuclearMedicine·2021· 1 cited
From Mice to Humans: The Exocrine Pancreas Does Not Matter in Human GLP-1 Receptor Imaging
Journal of Nuclear Medicine·2021· 4 citedOpen Access
Molecular Imaging of Diabetes
Molecular Imaging·2021Open Access
Contributors
Molecular Imaging·2021Open Access
Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68Ga]Ga-DOTA-E-[c(RGDfK)]2 PET/CT
European Journal of Nuclear Medicine and Molecular Imaging·2020· 18 citedOpen Access
Good Better Beta. Development and characterization of novel beta cell tracers
Data Archiving and Networked Services (DANS)·2020Open Access
PET/MRI enables simultaneous <i>in vivo</i> quantification of β-cell mass and function
Theranostics·2019· 22 citedOpen Access
Measuring the Pancreatic β Cell Mass in Vivo with Exendin SPECT during Hyperglycemia and Severe Insulitis
Molecular Pharmaceutics·2019· 15 cited
Exendin‐4 analogs in insulinoma theranostics
Journal of Labelled Compounds and Radiopharmaceuticals·2019· 75 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Martin Gotthardt(27), Otto C. Boerman(26), Maarten Brom(24), Wim J.G. Oyen(10), Cathelijne Frielink(10), Peter Laverman(9), Stefanie M. A. Willekens(7), Inge van der Kroon(6), Annemarie Eek(5), Martin Béhé(5), Desirée L. Bos(5), Karolina M. Andralojc(4), Décio L. Eizirik(4), Susan Roosenburg(4), Θεοδοσία Μάινα(4), Elisabeth von Guggenberg(4), Marion de Jong(3), Petra Kolenc Peitl(3), Jane Sosabowski(3), Theodorus J.P. Jansen(3)